CORZ Slide Deepens as Insiders Split and Shorts Hold Firm

Short sellers have not moved much, and that itself is the story. Short interest holds at 20.2% of the free float — essentially unchanged from the 20.5% reported in last week's note, and down only modestly from the 24%+ levels of early July. The gradual compression stalled weeks ago. Bears are not adding aggressively, but they are emphatically not covering either. The borrow market confirms there is no squeeze mechanics at work: availability has actually loosened to 212%, up 16% on the week, meaning there are more than two shares available to borrow for every share already shorted. Cost to borrow has edged higher, rising 35% on the week to 0.58% — but that remains negligible in absolute terms. The ORTEX short score of 67.5, down slightly from 68.9 a fortnight ago, is off its recent peak but still comfortably elevated, indicating the short thesis retains structural support.

Options traders are fractionally more bullish than usual, which cuts against the prevailing caution. The put/call ratio has drifted down to 0.45, about 1.4 standard deviations below its 20-day average of 0.47 — a mild call-side lean near the lower end of its one-year range of 0.24 to 0.63. It is a modest divergence from the short book's patience, suggesting some participants are positioning for a bounce rather than further downside.

The analyst community has leaned constructively since earnings, but the timing has grown stale and the gap between targets and price has widened uncomfortably. B. Riley raised its target to $42 and Macquarie to $38 in late July and early August. Those moves pushed the mean target to $37.13 — implying more than 125% upside from Friday's close. That gap is notable for two reasons: it reflects genuine analyst conviction that the AI and HPC infrastructure buildout underpins a multi-year re-rating, and it also reflects the fact that the stock has since fallen another 12% since those revisions. The bull case centres on the CRWV contract and a growing pipeline of high-density colocation opportunities. The bear case, and what shorts appear to be sitting on, is customer concentration — a majority of projected HPC capacity tied to a single counterparty — and the risk that regulatory or financing delays push out the revenue ramp.

Insider activity adds one more layer of complexity. The CLO, Todd DuChene, has sold stock on seven separate occasions since late July, totalling roughly $800,000 in proceeds across a price range of $17 to $23. Those are relatively small in dollar terms and may reflect a pre-arranged plan. Against that, two independent directors — Elizabeth Crain and Eric Weiss — bought shares in the $18–$19 range last week, committing roughly $245,000 combined as the stock was falling. Board-level open-market buying into a 20% drawdown is not noise; it is at minimum a signal that the directors see the current price as mispriced relative to the company's trajectory.

The next formal catalyst is November 2 earnings. Between now and then, the key variable is whether CRWV contract deployment milestones produce any tangible update — and whether the broader crypto and AI infrastructure trade stabilises enough to arrest the sector-wide selling that has pulled CORZ down alongside names with very different fundamental profiles.